How the ‘NHS model’ to tackle antimicrobial resistance (AMR) can set a global standard
NHS England and Improvement, in collaboration with the National Institute for Health and Care Excellence (NICE) and the Department of Health and Social Care (DHSC), has selected the first antimicrobial drugs to be purchased via the UK’s innovative ‘subscription-type’ payment model.
NHS England and Improvement project leads, Mark Perkins and David Glover, discuss this important step in tackling antimicrobial resistance (AMR).
AMR refers to the process by which microorganisms develop defences against antimicrobial drugs, enabling these microorganisms to adapt and become resistant to treatment. It’s a serious problem and has recently been identified as one of the World Health Organization’s top 13 global health challenges in the next decade. Without working antibiotics, routine surgery like caesarean sections or hip replacements will become too dangerous to perform, cancer chemotherapy will become prohibitively high-risk and certain infections will require long and complex treatment; or will no longer be treatable.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!